ADGRL3
Adhesion G protein-coupled receptor L3
Also known as: AGRL3_HUMAN, KIAA0768, LEC3, LPHN3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HAR2
- Gene
- ADGRL3
- Ensembl
- ENSG00000150471
- Chromosome
- 4
- Canonical length
- 1447 aa
- Protein class
- G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the latrophilin subfamily of G-protein coupled receptors (GPCR). Latrophilins may function in both cell adhesion and signal transduction. In experiments with non-human species, endogenous proteolytic cleavage within a cysteine-rich GPS (G-protein-coupled-receptor proteolysis site) domain resulted in two subunits (a large extracellular N-terminal cell adhesion subunit and a subunit with substantial similarity to the secretin/calcitonin family of GPCRs) being non-covalently bound at the cell membrane. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1447 residues, UniProt reviewed canonical sequence.
>Q9HAR2|ADGRL3
1 MWPSQLLIFM MLLAPIIHAF SRAPIPMAVV RRELSCESYP IELRCPGTDV IMIESANYGR
61 TDDKICDSDP AQMENIRCYL PDAYKIMSQR CNNRTQCAVV AGPDVFPDPC PGTYKYLEVQ
121 YECVPYKVEQ KVFLCPGLLK GVYQSEHLFE SDHQSGAWCK DPLQASDKIY YMPWTPYRTD
181 TLTEYSSKDD FIAGRPTTTY KLPHRVDGTG FVVYDGALFF NKERTRNIVK FDLRTRIKSG
241 EAIIANANYH DTSPYRWGGK SDIDLAVDEN GLWVIYATEQ NNGKIVISQL NPYTLRIEGT
301 WDTAYDKRSA SNAFMICGIL YVVKSVYEDD DNEATGNKID YIYNTDQSKD SLVDVPFPNS
361 YQYIAAVDYN PRDNLLYVWN NYHVVKYSLD FGPLDSRSGQ AHHGQVSYIS PPIHLDSELE
421 RPSVKDISTT GPLGMGSTTT STTLRTTTLS PGRSTTPSVS GRRNRSTSTP SPAVEVLDDM
481 TTHLPSASSQ IPALEESCEA VEAREIMWFK TRQGQIAKQP CPAGTIGVST YLCLAPDGIW
541 DPQGPDLSNC SSPWVNHITQ KLKSGETAAN IARELAEQTR NHLNAGDITY SVRAMDQLVG
601 LLDVQLRNLT PGGKDSAARS LNKAMVETVN NLLQPQALNA WRDLTTSDQL RAATMLLHTV
661 EESAFVLADN LLKTDIVREN TDNIKLEVAR LSTEGNLEDL KFPENMGHGS TIQLSANTLK
721 QNGRNGEIRV AFVLYNNLGP YLSTENASMK LGTEALSTNH SVIVNSPVIT AAINKEFSNK
781 VYLADPVVFT VKHIKQSEEN FNPNCSFWSY SKRTMTGYWS TQGCRLLTTN KTHTTCSCNH
841 LTNFAVLMAH VEVKHSDAVH DLLLDVITWV GILLSLVCLL ICIFTFCFFR GLQSDRNTIH
901 KNLCISLFVA ELLFLIGINR TDQPIACAVF AALLHFFFLA AFTWMFLEGV QLYIMLVEVF
961 ESEHSRRKYF YLVGYGMPAL IVAVSAAVDY RSYGTDKVCW LRLDTYFIWS FIGPATLIIM
1021 LNVIFLGIAL YKMFHHTAIL KPESGCLDNI KSWVIGAIAL LCLLGLTWAF GLMYINESTV
1081 IMAYLFTIFN SLQGMFIFIF HCVLQKKVRK EYGKCLRTHC CSGKSTESSI GSGKTSGSRT
1141 PGRYSTGSQS RIRRMWNDTV RKQSESSFIT GDINSSASLN REGLLNNARD TSVMDTLPLN
1201 GNHGNSYSIA SGEYLSNCVQ IIDRGYNHNE TALEKKILKE LTSNYIPSYL NNHERSSEQN
1261 RNLMNKLVNN LGSGREDDAI VLDDATSFNH EESLGLELIH EESDAPLLPP RVYSTENHQP
1321 HHYTRRRIPQ DHSESFFPLL TNEHTEDLQS PHRDSLYTSM PTLAGVAATE SVTTSTQTEP
1381 PPAKCGDAED VYYKSMPNLG SRNHVHQLHT YYQLGRGSSD GFIVPPNKDG TPPEGSSKGP
1441 AHLVTSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADGRL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 23 nTPM
- amygdala: 18 nTPM
- basal ganglia: 16 nTPM
- blood vessel: 15 nTPM
- midbrain: 14 nTPM
- hypothalamus: 14 nTPM
Single-cell type
- bergmann glia: 4,936 nCPM
- oligodendrocyte progenitor cells: 3,266 nCPM
- brain inhibitory neurons: 1,763 nCPM
- astrocytes: 1,637 nCPM
- brain excitatory neurons: 1,495 nCPM
- other brain neurons: 1,207 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 105 nTPM
- cerebral cortex: 102 nTPM
- midbrain: 91 nTPM
- basal ganglia: 90 nTPM
- amygdala: 89 nTPM
- thalamus: 84 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating G protein-coupled receptor signaling pathway
- cell surface receptor signaling pathway
- cell-cell adhesion via plasma-membrane adhesion molecules
- excitatory synapse assembly
- G protein-coupled receptor signaling pathway
- neuron migration
- Rho-activating G protein-coupled receptor signaling pathway
- synapse assembly
Molecular functions
- calcium ion binding
- carbohydrate binding
- cell adhesion mediator activity
- G protein-coupled receptor activity
- molecular condensate scaffold activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPS motif
- GPCR, family 2, secretin-like
- D-galactoside/L-rhamnose binding SUEL lectin domain
- GPCR, family 2, extracellular hormone receptor domain
- Olfactomedin-like domain
- GPCR, family 2, latrophilin, C-terminal
- GPCR, family 2, latrophilin
- GPCR, family 2-like, 7TM
- GPCR, family 2, secretin-like, conserved site
- AGRL2-4 , GAIN subdomain A
- GPCR family 2, extracellular hormone receptor domain superfamily
- D-galactoside/L-rhamnose binding SUEL lectin domain superfamily
- GAIN domain superfamily
- GAIN, subdomain B
- 7 transmembrane receptor (Secretin family)
- GPCR proteolysis site, GPS, motif
- D-galactoside/L-rhamnose binding SUEL lectin domain
- Olfactomedin-like domain
- Latrophilin Cytoplasmic C-terminal region
- Hormone receptor domain
- AGRL2-4 GAIN subdomain A
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADGRL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADGRL3 as an antibody target. Whether an autoantibody or antibody against ADGRL3 could matter depends on whether native ADGRL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADGRL3 is annotated at the cell surface, where native ADGRL3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADGRL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...